073P Institute of Education, London
Winter Meeting December 2005

 

Release of interleukin 1ß from spinal microglia in the rat isolated dorsal horn

Anna K. Clark, Sophie Pezet, Stephen B. McMahon and Marzia Malcangio. Neurorestoration group, Wolfson Centre for Age Related Diseases, King’s College London, London, SE1 1UL

Mounting evidence supports a role for inflammatory mediators released by activated spinal microglia in the maintenance of persistent pain states (Watkins & Maier, 2003). We evaluated whether activation of microglial cells in the dorsal horn released quantifiable levels of the proinflammatory cytokine Interleukin1 β (IL1 b ). We used an in vitro rat dorsal horn preparation (Malcangio & Bowery, 1996) to chemically stimulate microglial by lipopolysaccharide (LPS) . We then examined the occurrence of microglial activation in the dorsal horn by quantification of phosphorylated p38 MAP kinase (p-p38) using immunohistochemistry (IHC).

Lumbar spinal cord from male Wistar rats were excised and dorsal slices with dorsal roots attached continuously superfused with oxygenated Krebs’ solution (1ml/min). Before and after stimulation three fractions were collected to assess basal and recovery IL1β levels respectively. Chemical stimulation of microglia with LPS (10μg/ml; Sigma) was applied for 8 min and superfusates assayed for IL1β content by ELISA. LPS stimulation of IL1 b release was also examined in the presence of either Tetrodotoxin (300nM; TTX; Tocris), the glial inhibitor Fluorocitrate (100μM; Sigma), the p38MAPK inhibitor SB203580 (10μM; Tocris) or the Caspase-1 inhibitor Z-VAD-FMK (10μM; Sigma). At the end of these experiments slices were prepared for IHC.

Following LPS application the levels of IL1 b in dorsal horn superfusates were increased to 574%±141 above basal levels (4.6±1.1pg/8ml fraction, n=5, P<0.05). In non-stimulated dorsal horn slices the mean p-p38 immunoreactivity (IR) was 31.2±2.6 fluorescence per 100μm2 (n=6). Following LPS superfusion p-p38 IR was increased to 93.2±9.2 fluorescence per 200μm2 (n= 6, P<0.001). In the presence of Fluorocitrate, SB203580 and Z-VAD-FMK, but not TTX, no significant increase in IL1β release or p38 phosphorylation occurred above basal levels following LPS activation of microglia (n=5-7).

IL1 b can be readily released in the dorsal horn following activation of microglia by LPS, via a p38 MAPK and Caspase-1 dependent mechanism. We suggest that this microglial cell-derived IL1 b may modulate central neuronal plasticity following peripheral nerve injury and spinal cord injury.

 

Malcangio, M. & Bowery, N.G. (1996). Pain, 66, 351 - 358.
Watkins, L.R. & Maier, S.F. (2003). Nat Rev Drug Discov, 2, 973 - 985.